Gifford Bioscience Expands with New Radiometric Laboratory

BIRMINGHAM, England, Oct. 16, 2026 /CourierPR/ -- Gifford Bioscience Limited, a preclinical contract research organization based at the BioHub Birmingham, has expanded its facilities with the addition of a dedicated radiometric laboratory. The new space, which opened in July 2026, is part of the company's ongoing efforts to support pharmaceutical and biotechnology companies in advancing their drug development pipelines.

Established in 2017, Gifford Bioscience specializes in providing radiometric studies, functional assays, surface plasmon resonance, and custom assay development. The company's work includes receptor pharmacology and occupancy studies for neuroscience, oncology, and metabolic diseases. The expansion of the radiometric laboratory is aimed at increasing capacity for radioligand binding, quantitative autoradiography, uptake and release, and receptor occupancy studies.

The BioHub Birmingham is a purpose-built biomedical incubator at Birmingham Research Park, designed to support life science companies from proof of concept through to expansion. Gifford Bioscience has been a resident of the BioHub since 2017. The expansion of the company's facilities is seen as a positive sign of the growing biomedical footprint in the region.

The new laboratory will allow Gifford Bioscience to handle a greater volume of client studies and custom assay development, thereby enhancing its services and capabilities. The company's work in receptor pharmacology and occupancy studies is critical for pharmaceutical and biotechnology companies as they seek to optimize drug candidates before moving them into clinical studies.

The expansion is part of Gifford Bioscience's ongoing commitment to supporting the drug discovery and development process. The company's services are designed to help organizations understand how a compound interacts with its target, providing valuable insights that can guide the decision-making process for advancing drug candidates.

Gifford Bioscience's presence at the BioHub Birmingham has been beneficial for both the company and the wider ecosystem. The facility management team at the BioHub has been supportive throughout the company's development and growth.

The expansion of Gifford Bioscience's radiometric laboratory marks a significant step in the company's growth and its continued support of the biomedical industry. As the company looks to the future, it remains committed to providing high-quality services that help pharmaceutical and biotechnology companies advance their drug development efforts.